首页> 外文期刊>Brachytherapy >A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate
【24h】

A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate

机译:一种新型尿道尿道保存技术,高剂量率前列腺近距离放射治疗前列腺切除后

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Purpose The purpose of this study was to assess retrospectively the variability of the urethral dose optimized using a Foley catheter versus urethral contrast injected using a new modified triple-lumen catheter, in CT-based high-dose-rate (HDR) prostate brachytherapy of posttransurethral resection of prostate (TURP) patients. Methods and Materials At our institution, there were six post-TURP patients with prostate carcinoma between July 2014 and April 2016 who underwent transperineal interstitial HDR brachytherapy (16 needles). A custom modified triple-lumen catheter was placed to inject contrast into the TURP defect. Three-dimensional optimal plans using inverse planning simulated annealing algorithm was generated according to radiation therapy oncology group dose requirements. Alternative plans were retroactively generated for comparison using standard technique based on a Foley catheter as a urethral constraint volume for each patient with the same weighting factors. We compared the dosimetry parameters in each planning using Wilcoxon's ranked sum nonparametric test. Results The median followup of all patients was 17.5 onths. No significant genitourinary or gastrointestinal toxicity was noted using this technique. In the dosimetric analysis, the prostate V 100 values and TURP urethral V 100 were significantly different between plans with and without the contrast ( V 100 [mean]: 92.4 [%] vs. 94.4 [%], p .046; TURP UV 100 [mean]: 1.4 vs. 2.2, p .028). There were no statistical differences in the mean values of planning target volume V 150 %, V 200 %, and D 90 , and each bladder V 75 and rectum V 75 . Conclusions Post-TURP HDR brachytherapy with urethral contrast showed significantly more volume effect of the TURP defect than that with a Foley catheter alone. Better visualization of the TURP defect should lead to more accurate urethral sparing administration of HDR brachytherapy which is necessary to prevent urethral complication.
机译:摘要目的本研究的目的是回顾性地评估使用新的修饰三腔导管注射的副导管与尿道对比度,以CT基的高剂量率(HDR)前列腺脱落放疗前列腺尿失体切除前列腺(TURP)患者。在我们机构的方法和材料,2014年7月和2016年7月之间有六个出现前列腺癌的TURP患者,他们接受过咽喉间质HDR近距离放射治疗(16针)。将一种定制改性的三腔导管放置以注入与草皮缺陷形成鲜明对比。使用逆计划模拟退火算法根据放射治疗肿瘤组剂量要求产生三维最佳计划。使用基于Foley导管的标准技术进行追溯地产生替代计划,作为具有相同加权因子的每位患者的尿道约束量。我们使用Wilcoxon的排名和非参数测试将所述剂量测定参数进行比较。结果所有患者的中位关注是17.5末。使用该技术没有注意到没有显着的泌尿生殖或胃肠道毒性。在剂量测定分析中,前列腺v 100值和TurP尿道v 100在具有和不具有对比度的计划之间显着差异(V 100 [表示]:92.4 [%]与94.4 [%],P.046; TURP UV 100 [均值]:1.4与2.2,p.028)。规划目标体积V150%,V 200%和D 90的平均值没有统计差异,每个膀胱V 75和直肠V 75。结论TURP后HDR近距离放射治疗尿道对比度显示出的草皮缺陷的体积效果明显,而不是单独使用Foley导管。更好地可视化的草图缺陷应导致更准确的尿道尿道保留施用HDR近距离放射治疗,这是预防尿道并发症的必要条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号